The 16th edition of CPHI & PMEC India Expo, orchestrated by Informa Markets, in India, will commence from from November 28th to November 30th, 2023, at the India Expo Centre in Greater Noida, Delhi.
The event, along with its ancillary programmes, spotlights technological strides pivotal in propelling India’s pharmaceutical machinery, technology, and ingredients sectors.
The Indian pharmaceutical industry, on the brink of significant expansion, eyes a projected CAGR of 13%, eyeing a market value of $102.7 billion (INR 8.5 lakh crores) by 2028.
According to a press statement, the expo aims to serve as a marketplace that connects various elements of the industry, including knowledge, technologies, and market opportunities.
“CPHI & PMEC India are anticipated to host over 1500 exhibitors and attract more than 45,000 visitors from over 150+ countries during the 3-day event. This provides a unique opportunity to directly engage with high-ranking pharmaceutical executives, buyers, procurement managers, contract manufacturers, hospital administrators, as well as representatives from National and State Regulatory Boards and policymakers,” as per a press statement.
The expo serves as a platform for these stakeholders to come together, conduct business, and explore innovative solutions to address economic uncertainties and domestic trade challenges in India, it added.
Notable exhibitors at the event include Dr. Reddy’s Laboratories Ltd, Biocon Ltd, Glenmark Lifesciences Ltd, Hetero Labs Limited, ACG, IMA Industria Macchine Automatiche S.P.A, Fette Compacting Machinery India Pvt. Ltd.
Ace Technologies & Packaging Systems Pvt. Ltd, DPB Antibiotics, Lee Pharma, Omniscient Health, hcare Pvt Ltd, Venkata Narayana Active Ingredients Pvt Ltd, Unilab Chemicals and Pharmaceuticals Pvt Ltd, and many others.
Moreover, they will exhibit products pertaining to AI-enhanced quality control, the latest technology, advanced drug delivery systems, sustainability initiatives, and pharmaceutical packaging innovations, fostering partnerships, collaborations, and industry advocacy.
This year, the expo continues to enjoy substantial support from key industry associations such as BDMA (Bulk Drug Manufacturing Association), FOPE (Federation of Pharma Entrepreneurs), KDPMA (Karnataka Drugs and Pharmaceuticals Manufacturers’ Association), OPPI (Organisation of Pharmaceutical Producers of India), and Pharmexcil (Pharmaceutical Export Promotion Council) solidifying its reputation as the industry’s most promising show.
“In 2023, the Indian pharma industry is experiencing the ‘Rise and Rise of India’— a perfect blend of a strong domestic manufacturing base, increasing innovation, and robust government support. With objectives laid down during the G20 presidency, the industry in India is poised to scale to US$ 65 billion by 2024 and surpass US$ 130 billion by 2030, driven by heightened pharmaceutical innovation, technological advancements, and a focus on breakthrough products. A vaccine manufacturing powerhouse, India leads by supplying over 60% of global vaccine demand. The future involves a growing production capacity, collaboration with private players, and a commitment to training 30 million professionals in digital skills by 2026,” Yogesh Mudras, Managing Director, Informa Markets in India said.
Within its realm, the India Pharma Week includes strategic avenues that provide a unique space for leaders to ideate on innovation, growth, direction, sustainability, and other crucial factors shaping the industry’s future, he added.
The CPHI & PMEC India Expo also includes the ‘India Pharma Week,’ a series of exclusive events crafted to captivate industry leaders and experts through diverse formats.
Additionally, the Pharma Leaders Roundtable is an exclusive, closed-door event that brings together senior leaders from prominent pharma companies. The Women in Pharma event is a half-day program dedicated to uplifting female representation and fostering diversity within the Indian pharmaceutical landscape.
Finally, the 10th edition of the India Pharma Awards acknowledges and celebrates excellence and innovation within the pharmaceutical space. This prestigious platform recognizes outstanding pharma brands for their notable contributions to the industry.
